{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T16:07:55Z","timestamp":1776960475945,"version":"3.51.4"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1097\/md.0000000000002052","type":"journal-article","created":{"date-parts":[[2015,11,11]],"date-time":"2015-11-11T12:51:44Z","timestamp":1447246304000},"page":"e2052","source":"Crossref","is-referenced-by-count":9,"title":["Extensive Metastatic Cholangiocarcinoma Associated With IgG4-Related Sclerosing Cholangitis Misdiagnosed as Isolated IgG4-Related Sclerosing Cholangitis"],"prefix":"10.1097","volume":"94","author":[{"given":"Yi-An","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-Zhong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Min","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao-Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-67-20210309","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000077991","article-title":"A review and update on cholangiocarcinoma.","volume":"66","author":"Olnes","year":"2004","journal-title":"Oncology"},{"key":"R2-67-20210309","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(05)67530-7","article-title":"Cholangiocarcinoma.","volume":"366","author":"Khan","year":"2005","journal-title":"Lancet"},{"key":"R3-67-20210309","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-2004-828895","article-title":"Surgical management of cholangiocarcinoma.","volume":"24","author":"Jarnagin","year":"2004","journal-title":"Semin Liver Dis"},{"key":"R4-67-20210309","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1056\/NEJM200103083441005","article-title":"High serum IgG4 concentrations in patients with sclerosing pancreatitis.","volume":"344","author":"Hamano","year":"2001","journal-title":"N Engl J Med"},{"key":"R5-67-20210309","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0016-5107(04)02229-1","article-title":"Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis.","volume":"60","author":"Nakazawa","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"R6-67-20210309","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00534-012-0521-y","article-title":"Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012.","volume":"19","author":"Ohara","year":"2012","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"R7-67-20210309","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease.","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol"},{"key":"R8-67-20210309","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4254\/wjh.v6.i3.144","article-title":"Hepatoprotective effect of silymarin.","volume":"6","author":"Vargas-Mendoza","year":"2014","journal-title":"World J Hepatol"},{"key":"R9-67-20210309","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/hep.510260316","article-title":"Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats.","volume":"26","author":"Boigk","year":"1997","journal-title":"Hepatology"},{"key":"R11-67-20210309","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease.","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"key":"R12-67-20210309","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","article-title":"Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy.","volume":"134","author":"Ghazale","year":"2008","journal-title":"Gastroenterology"},{"key":"R14-67-20210309","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00535-011-0465-z","article-title":"Diagnostic criteria for IgG4-related sclerosing cholangitis based on cholangiographic classification.","volume":"47","author":"Nakazawa","year":"2012","journal-title":"Journal of gastroenterology"},{"key":"R15-67-20210309","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s00535-007-2038-8","article-title":"Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis.","volume":"42","author":"Nishino","year":"2007","journal-title":"J Gastroenterol"},{"key":"R16-67-20210309","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1378\/chest.12-2954","article-title":"Significance of lymphadenopathy in IgG4-related sclerosing disease and sarcoidosis.","volume":"143","author":"Srivali","year":"2013","journal-title":"Chest"},{"key":"R17-67-20210309","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00535-012-0744-3","article-title":"Current concept and diagnosis of IgG4-related disease in the hepato-bilio-pancreatic system.","volume":"48","author":"Okazaki","year":"2013","journal-title":"J Gastroenterol"},{"key":"R18-67-20210309","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1445-5994.2012.02964.x","article-title":"Extra-pancreatic manifestations of IgG4-related systemic disease: a single-centre experience of treatment with combined immunosuppression.","volume":"43","author":"Bosco","year":"2013","journal-title":"Intern Med J"},{"key":"R19-67-20210309","first-page":"103","article-title":"IgG4-related disease: why high IgG4 and fibrosis Arthritis Res T","volume":"15","author":"Koike","year":"2013","journal-title":"her"},{"key":"R20-67-20210309","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00428-011-1073-2","article-title":"IgG4-associated cholangitis with cholangiocarcinoma.","volume":"458","author":"Straub","year":"2011","journal-title":"Virchows Arch"},{"key":"R21-67-20210309","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/jgh.12248","article-title":"Establishment of a serum IgG4 cut-off value for the differential diagnosis of IgG4-related sclerosing cholangitisa Japanese cohort.","volume":"28","author":"Ohara","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"R22-67-20210309","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/hep.24487","article-title":"Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma.","volume":"54","author":"Oseini","year":"2011","journal-title":"Hepatology"},{"key":"R23-67-20210309","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1007\/s10620-012-2401-3","article-title":"Increased serum levels of carbohydrate antigen 19-9 and outcomes in primary sclerosing cholangitis patients without cholangiocarcinoma.","volume":"58","author":"Venkatesh","year":"2013","journal-title":"Dig Dis Sci"},{"key":"R24-67-20210309","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S1470-2045(08)70001-9","article-title":"CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial.","volume":"9","author":"Hess","year":"2008","journal-title":"Lancet Oncol"},{"key":"R25-67-20210309","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/cncr.27734","article-title":"Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy: a pooled analysis of 6 prospective trials.","volume":"119","author":"Bauer","year":"2013","journal-title":"Cancer"},{"key":"R26-67-20210309","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11684-010-0240-1","article-title":"Serum carbohydrate antigen (CA) 19-9 as a prognostic factor in cholangiocarcinoma: a meta-analysis.","volume":"4","author":"Liu","year":"2010","journal-title":"Front Med China"},{"key":"R27-67-20210309","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1007\/s10620-005-2927-8","article-title":"The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis.","volume":"50","author":"Levy","year":"2005","journal-title":"Dig Dis Sci"},{"key":"R28-67-20210309","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1749-8090-8-160","article-title":"IgG4-related lung disease showing high standardized uptake values on FDG-PET: report of two cases.","volume":"8","author":"Kitada","year":"2013","journal-title":"J Cardiothorac Surg"},{"key":"R29-67-20210309","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1093\/rheumatology\/ket182","article-title":"Clinical implication of FDG-PETCT in monitoring disease activity in IgG4-related disease.","volume":"52","author":"Taniguchi","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"R30-67-20210309","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.crad.2011.10.011","article-title":"Utility of FDG PETCT in IgG4-related systemic disease.","volume":"67","author":"Nakatani","year":"2012","journal-title":"Clin Radiol"},{"key":"R31-67-20210309","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1007\/s00259-014-2729-3","article-title":"Characterizing IgG4-related disease with (1)(8)F-FDG PETCT: a prospective cohort study.","volume":"41","author":"Zhang","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R32-67-20210309","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00535-007-2132-y","article-title":"Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography.","volume":"43","author":"Ozaki","year":"2008","journal-title":"J Gastroenterol"},{"key":"R33-67-20210309","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/canjclin.56.2.69","article-title":"Chronic inflammation: a common and important factor in the pathogenesis of neoplasia.","volume":"56","author":"Schottenfeld","year":"2006","journal-title":"CA Cancer J Clin"},{"key":"R34-67-20210309","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJM200107123450215","article-title":"High serum IgG4 concentrations in patients with sclerosing pancreatitis.","volume":"345","author":"Aithal","year":"2001","journal-title":"N Engl J Med"},{"key":"R35-67-20210309","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","article-title":"Foxp3CD25CD4natural regulatory T cells in dominant self-tolerance and autoimmune disease.","volume":"212","author":"Sakaguchi","year":"2006","journal-title":"Immunol Rev"},{"key":"R36-67-20210309","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ni1181","article-title":"Natural regulatory T cells in infectious disease.","volume":"6","author":"Belkaid","year":"2005","journal-title":"Nat Immunol"},{"key":"R37-67-20210309","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1245\/s10434-012-2268-8","article-title":"Intratumoral IL-17() cells and neutrophils show strong prognostic significance in intrahepatic cholangiocarcinoma.","volume":"19","author":"Gu","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"R38-67-20210309","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/hep.25627","article-title":"Significance of immunoglobulin G4 (IgG4)-positive cells in extrahepatic cholangiocarcinoma: molecular mechanism of IgG4 reaction in cancer tissue.","volume":"56","author":"Harada","year":"2012","journal-title":"Hepatology"},{"key":"R39-67-20210309","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.humpath.2012.03.001","article-title":"Pathologic significance of immunoglobulin G4-positive plasma cells in extrahepatic cholangiocarcinoma.","volume":"43","author":"Kimura","year":"2012","journal-title":"Hum Pathol"},{"key":"R40-67-20210309","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000354539","article-title":"Gemcitabine plus cisplatin versus capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer: a retrospective cohort study.","volume":"59","author":"Woo","year":"2013","journal-title":"Chemotherapy"},{"key":"R41-67-20210309","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/annonc\/mdt540","article-title":"Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials.","volume":"25","author":"Valle","year":"2014","journal-title":"Ann Oncol"},{"key":"R42-67-20210309","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1586\/egh.10.45","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.","volume":"4","author":"Weigt","year":"2010","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R44-67-20210309","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1158\/1078-0432.CCR-13-3006","article-title":"Phase II results of Dovitinib (TKI258) in patients with metastatic renal cell cancer.","volume":"20","author":"Escudier","year":"2014","journal-title":"Clin Cancer Res"},{"key":"R45-67-20210309","doi-asserted-by":"crossref","first-page":"e1004135","DOI":"10.1371\/journal.pgen.1004135","article-title":"Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma.","volume":"10","author":"Borad","year":"2014","journal-title":"PLoS Genet"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000002052","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:54:20Z","timestamp":1620960860000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201511110-00067"}},"subtitle":["A Case Report and Literature Review"],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":42,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000002052","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}